ADK (ADK) News
Follow ADK (ADK) news in one place: company catalysts, earnings, analyst actions and wider market developments. Review 3 public stories across 2 publication days to understand how the story developed. Public news appears after a 15-minute delay; LiveCast subscribers can follow new headlines and hear important updates without this additional delay.
L
Diagnos Inc. (ADK) Files FDA 513(g) for CARA System Classification
Diagnos Inc. submitted a Section 513(g) request to the U.S. FDA to determine classification and regulatory requirements for its CARA System, following prior FDA pre-submission.Material DetailsContext by AI AnalystThis is
REGULATION | Sep 28, 2026, 03:58 PM UTC
L
DIAGNOS Advances Regulatory Strategy with US FDA Submission for CARA System
BROSSARD, Quebec, Sept. 28, 2026 (GLOBE NEWSWIRE) -- Diagnos Inc. (“DIAGNOS” or the “Corporation”) (TSX Venture: ADK, OTCQB: DGNOF, FWB: 4D4A), a Corporation dedicated to the early detection of eye-related health using A
REGULATION | Sep 28, 2026, 03:58 PM UTC
L
Diagnos, Altius, Emperor Metals at 52-Week High on News
Diagnos, Altius, Emperor Metals at 52-Week High on News
EQUITY | Aug 28, 2026, 03:36 PM UTC